Luye Pharma Group Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Dian Bo Liu
Algemeen directeur
CN¥4.2m
Totale compensatie
Percentage CEO-salaris | 75.1% |
Dienstverband CEO | 21.3yrs |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | 12.8yrs |
Gemiddelde ambtstermijn bestuur | 10.4yrs |
Recente managementupdates
Recent updates
Unpleasant Surprises Could Be In Store For Luye Pharma Group Ltd.'s (HKG:2186) Shares
Sep 25Does Luye Pharma Group (HKG:2186) Have A Healthy Balance Sheet?
Aug 29Luye Pharma Group Ltd.'s (HKG:2186) Earnings Haven't Escaped The Attention Of Investors
Jun 19We Discuss Why Luye Pharma Group Ltd.'s (HKG:2186) CEO Compensation May Be Closely Reviewed
May 21Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden
Apr 26Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?
Feb 29Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S
Jan 09Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt
Dec 19A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)
Nov 24Is Luye Pharma Group (HKG:2186) A Risky Investment?
Sep 12Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price
Aug 17Is Luye Pharma Group (HKG:2186) Using Too Much Debt?
May 10We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt
Sep 20Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook
Apr 06Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares
Mar 17Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Jun 30 2024 | n/a | n/a | CN¥770m |
Mar 31 2024 | n/a | n/a | CN¥652m |
Dec 31 2023 | CN¥4m | CN¥3m | CN¥533m |
Sep 30 2023 | n/a | n/a | CN¥495m |
Jun 30 2023 | n/a | n/a | CN¥458m |
Mar 31 2023 | n/a | n/a | CN¥531m |
Dec 31 2022 | CN¥3m | CN¥3m | CN¥605m |
Sep 30 2022 | n/a | n/a | CN¥190m |
Jun 30 2022 | n/a | n/a | -CN¥224m |
Mar 31 2022 | n/a | n/a | -CN¥179m |
Dec 31 2021 | CN¥4m | CN¥3m | -CN¥134m |
Sep 30 2021 | n/a | n/a | CN¥210m |
Jun 30 2021 | n/a | n/a | CN¥554m |
Mar 31 2021 | n/a | n/a | CN¥630m |
Dec 31 2020 | CN¥5m | CN¥4m | CN¥707m |
Sep 30 2020 | n/a | n/a | CN¥955m |
Jun 30 2020 | n/a | n/a | CN¥1b |
Mar 31 2020 | n/a | n/a | CN¥1b |
Dec 31 2019 | CN¥4m | CN¥3m | CN¥1b |
Sep 30 2019 | n/a | n/a | CN¥1b |
Jun 30 2019 | n/a | n/a | CN¥1b |
Mar 31 2019 | n/a | n/a | CN¥1b |
Dec 31 2018 | CN¥4m | CN¥3m | CN¥1b |
Sep 30 2018 | n/a | n/a | CN¥1b |
Jun 30 2018 | n/a | n/a | CN¥1b |
Mar 31 2018 | n/a | n/a | CN¥1b |
Dec 31 2017 | CN¥4m | CN¥3m | CN¥981m |
Compensatie versus markt: De totale vergoeding ($USD 589.39K ) Dian Bo } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 495.08K ).
Compensatie versus inkomsten: De vergoeding van Dian Bo is het afgelopen jaar met meer dan 20% gestegen.
CEO
Dian Bo Liu (58 yo)
21.3yrs
Tenure
CN¥4,180,000
Compensatie
Mr. Dian Bo Liu is a Co-Founder of Luye Pharma Group Ltd. in 1994 and serves as its Head of Corporate Directions & Strategies and has been its Chief Executive Officer since July 2003. Mr. Liu is responsibl...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 21.3yrs | CN¥4.18m | geen gegevens | |
Co-Founder & Vice Executive Chairman | 21.3yrs | CN¥3.09m | geen gegevens | |
Co-Founder & Executive Director | no data | CN¥1.46m | geen gegevens | |
Executive Director | no data | CN¥1.50m | geen gegevens | |
Chief Financial Officer | 12.8yrs | geen gegevens | geen gegevens | |
Company Secretary | 3.9yrs | geen gegevens | geen gegevens |
12.8yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 2186 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 12.8 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Co-Founder | 21.3yrs | CN¥4.18m | geen gegevens | |
Co-Founder & Vice Executive Chairman | 21.3yrs | CN¥3.09m | geen gegevens | |
Co-Founder & Executive Director | 21.3yrs | CN¥1.46m | geen gegevens | |
Executive Director | 10.7yrs | CN¥1.50m | geen gegevens | |
Independent Non-Executive Director | 10.4yrs | CN¥269.00k | geen gegevens | |
Independent Non-Executive Director | 10.4yrs | CN¥322.00k | geen gegevens | |
Non-Executive Director | 7.7yrs | CN¥269.00k | geen gegevens | |
Independent Non-Executive Director | 10.4yrs | CN¥269.00k | geen gegevens | |
Independent Non-Executive Director | 10.4yrs | CN¥269.00k | geen gegevens | |
Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
Independent Non-Executive Director | 1.5yrs | CN¥162.00k | geen gegevens |
10.4yrs
Gemiddelde duur
61yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 2186 zijn ervaren en ervaren (gemiddelde ambtstermijn van 10.4 jaar).